Big Picture Medicine Dr Mustafa Sultan

Dr Molly Gilmartin is an Investment Manager at AlbionVC who manage over $1bn in assets and have invested in companies like Arecor, Healios and Pando.

She studied Medicine at Oxford, was a founding team member of Pando, Chief Commerical Officer of Induction Healthcare, a Consultant at McKinsey and now an Investor at AlbionVC.

We talk a lot about the psychology of communication, about strength-based feedback and radical candour, about how being inquisitive can get you very far, how energy is Molly’s superpower and lots of other frameworks that Molly finds useful in her career. We finish off by discussing her thesis on the emerging B2C2B model in healthcare.

This is a really value packed interview — I hope you enjoy.

Video Interview on Youtube.

You can find me on Twitter @MustafaSultan and subscribe to my newsletter on www.musty.io

Joe Stringer is a Partner at Octopus Ventures, one of the largest European Venture Capital firms with £1.8 billion under management.

He was Partner at Ernst & Young for 10 years, before leaving his cushy position to launch his own venture fund TenX Health. He then led Google Health in the UK before becoming Partner at Octopus Ventures.

We talk about his thesis on the future of health, the importance of hard work, grit and resilience, as well as building and managing relationships — in particular, trying not to be too British.

You can find me on Twitter @MustafaSultan and subscribe to my newsletter on www.musty.io

Dr Patrick Malone is an MD, as well as having a PhD in Neuroscience. His research focused on computational cognitive neuroscience and AI applications in radiology.

In 2020, he joined the investment team at Northpond Ventures where he invests in early-stage health-tech and deep-tech companies.

Patrick put together a viral Twitter thread on his transition from Medicine and Research into Venture Capital. In 40 tweets, he detailed his high yield advice on networking, communication and which skills are useful to develop. Essentially a Bible on some of the meta skills needed to have impact at scale in healthcare.

In this episode we discuss that thread — and I ask Patrick to expand on some of those meta skills, and we also talk about his thesis on the future of healthcare.

I think this is a super valuable interview — I hope you enjoy.

Video interview on YouTube.

You can find me on Twitter @MustafaSultan and subscribe to my newsletter on www.musty.io

Niklas Rindtorff is a Physician-Scientist and one of the Pioneers in decentralised healthcare and life sciences.

He has an MD from Heidelberg University and he received his Master's Degree in Biomedical Informatics from Harvard Medical School as a Fulbright Scholar.

He is a founder of LabDAO, an online community of life scientists collaborating to increase the accessibility of life science tools both in the dry lab and wet lab. He’s also a Core Member of VitaDAO, a collective funding early stage longevity research.

DAOs are Decentralised Autonomous Organisations and a staple of the ongoing WEB3 revolution.

Investopedia defines DAOs as having no central governing body, every member within a DAO typically shares a common goal and attempts to act in the best interest of the entity. Popularized through cryptocurrency enthusiasts and blockchain technology, DAOs are used to make decisions in a bottom-up management approach.

Or as Niklas describes them, DAOs are basically a WhatsApp group chat with an attached cryptocurrency bank account.

In this conversation, I find out about how DAOs can be used in healthcare. From enabling rare disease research to fixing science’s publishing problems. I hope you enjoy.

You can find me on Twitter @MustafaSultan and subscribe to my newsletter on www.musty.io

Nikhil Patel is the Founder and CEO of Craniometrix, where they’re using innovative deep learning and digital health tools to diagnose Alzheimer’s Disease — and position themselves as the all-in-one Alzheimer’s care platform.

Nikhil studied Computer Science and Economics at Yale University, before launching Craniometrix — which was accepted into Y Combinator and have raised $6M in their seed round.

We talk about how he’s been able to build Craniometrix as a 22-year-old and get investors really excited about his vision, how a digital tool can unlock new levels of diagnostic ability and why Nikhil talks so fast.

You can find me on Twitter @MustafaSultan and subscribe to my newsletter on www.musty.io

Neil Daly is the Founder and CEO of Skin Analytics; a company which uses AI to detect skin cancer. 

Neil started Skin Analytics in 2012 after working extensively in mobile innovation and strategy consulting. They’ve raised a total of $9M.

If detected early, melanoma can have a 99% survival rate — which dramatically decreases the later it’s picked up — creating a very important opportunity for companies like Skin Analytics.

But there are some important caveats to clear up. For example, I ask Neil: Whose fault is it when the algorithm misses a cancer? The doctor’s or the algorithm's?

I also ask if algorithms are unfairly held to a higher standard than human doctors, and we speak about the making of the Skin Analytics algorithm — and how it broke away from conventional wisdom.

You can find me on Twitter @MustafaSultan and subscribe to my newsletter on www.musty.io